Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the study record remains unavailable on the error page.
    Difference
    0.2%
    Check dated 2026-10-31T13:25:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    1%
    Check dated 2026-10-24T14:54:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T14:50:55.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:51:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content. This indicates an access restriction or server issue preventing viewing the trial details.
    Difference
    0.5%
    Check dated 2026-09-26T16:40:08.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual study content. Core study details and attached documents are no longer accessible from this page.
    Difference
    19%
    Check dated 2026-09-19T18:52:45.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.